Clinical and laboratory profile of dengue infection in children

G S Shah1, S Islam, B K Das

  • 1Department of Paediatrics, B P Koirala Institute of Health Sciences, Dharan, Nepal. gaurisshah@yahoo.com

Insights

Most children with dengue infection in Bangladesh experienced severe forms like dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), not classical dengue fever (DF). Secondary infections were more common, highlighting the need for prompt diagnosis and management of severe dengue in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Dengue infection poses a significant public health challenge, particularly in tropical and subtropical regions.
  • Understanding the clinical spectrum and risk factors for severe dengue is crucial for effective patient management.

Purpose of the Study:

  • To investigate the clinical characteristics and serological profiles of dengue infections in children admitted to a hospital in Dhaka, Bangladesh.
  • To differentiate between primary and secondary dengue infections and their association with disease severity.

Main Methods:

  • A prospective, observational study of 100 seropositive dengue cases in children aged 8 months to 14 years.
  • Serological testing using rapid strip tests to determine immunoglobulin M (IgM) and immunoglobulin G (IgG) status.
  • Clinical data collection including symptoms, physical examination findings, and laboratory values.

Main Results:

  • 85% of cases had secondary dengue infection (IgG positive), while 15% had primary infection (IgM positive).
  • 89% of children presented with severe dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS), compared to 11% with classical dengue fever (DF).
  • Common symptoms included fever, vomiting, abdominal pain, and bleeding; severe cases showed higher rates of tachycardia, hypotension, hepatomegaly, high hematocrit, and thrombocytopenia.

Conclusions:

  • Secondary dengue infections are predominant in this pediatric cohort, associated with a high burden of severe DHF/DSS.
  • Clinical indicators like fever, vomiting, musculoskeletal pain, bleeding, hepatomegaly, thrombocytopenia, and high hematocrit warrant strong suspicion for DHF/DSS in epidemic settings.
  • Further research into the pathogenesis of bleeding manifestations in dengue is needed, as tourniquet test and thrombocytopenia did not consistently correlate with bleeding.

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...